More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian
President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else
From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
Phase 1 study showed some patients with relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) achieved a remission with...
Company Signs Definitive Agreement to Acquire Health Clinics LimitedTORONTO, ON / ACCESSWIRE / August 17, 2021 / StageZero Life Sciences...
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (“Better Choice” or “the Company”),...
Integration — and Automation — of Referral and Prior Authorization Workflows Improves Care TransitionsNEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE)...
A visual of Ampligen as an intranasal therapy A visual of Ampligen as an intranasal therapy OCALA, Fla., Aug. 17,...
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
New site enhances the user experience and offers expanded content for depression sufferersMALVERN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) --...
VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB:...
New study shows advanced treatment (AT) for management of LEDUs among Medicare beneficiaries is associated with significant reductions in major...
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired...
Double-blind, randomized trial data show a clinically meaningful and statistically significant net reduction of 8.1 mmHg in 24-hour ambulatory systolic...
SAN FRANCISCO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A new study by One Medical (NASDAQ: ONEM), a leading national member-based...
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering...
NEEDHAM, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”), a late clinical stage biopharmaceutical company developing novel...
OREM, Utah, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
- Members include world-leading experts in fields of immunotherapy drug discovery and development and commercial oncology therapeutics - - Dr....
MISSISSAUGA, Ontario, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...
Top-line data anticipated in late 2021 Single Phase 3 trial serves as basis for global regulatory filings SAN DIEGO and CAMBRIDGE,...
Virtual Presentation to be led by PolyPid Co-Founder and CSO on August 28, 2021PETACH TIKVA, Israel, Aug. 17, 2021 (GLOBE NEWSWIRE)...
CARLSBAD, Calif.,, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announces its intention to prioritize its...
